Table 3.
Latent variable of PASC symptoms | ||||
---|---|---|---|---|
Objective signs of dysfunction | Coefficient | p | 95% CI | |
Weight loss (⩽ 5% of BMI value prior to COVID-19)a | 0.258 | 0.003 | 0.090 | 0.426 |
Reduced resting oxygen saturation (⩽92%) | 0.200 | 0.211 | –0.113 | 0.513 |
Decreased oxygen saturation during effortb | 0.029 | 0.985 | –0.303 | 0.309 |
Reduced number of repetitions during sit-to-stand test | 0.577 | <0.001 | 0.382 | 0.772 |
Reduced handgrip strength | 0.243 | 0.007 | 0.065 | 0.420 |
COVID-related abnormalities at X-ray | –0.031 | 0.727 | –0.208 | 0.145 |
FVC <80% of predicted at spirometry test | –0.27 | 0.760 | –0.202 | 0.147 |
eGFR lower than 60 ml/min/1.73 m2 (in subjects with no previous history of kidney disease)c | 0.141 | 0.277 | –0.113 | 0.394 |
CI, confidence intervals; BMI, body mass index; FVC, forced vital capacity; eGFR, estimated glomerular filtration rate.
Difference between current BMI measurement and calculated BMI based on self-reported estimates of body weight prior to COVID-19.
Oxygen saturation reduction of ⩾4 points during sit-to-stand test (not undertaken in subjects presenting resting pulse oximetry ratings lower than 90%).
Estimated glomerular filtration rate calculated according to CKD EPI30.